The latest closing stock price for 4D Molecular Therapeutics as of November 22, 2024 is 7.79.
An investor who bought $1,000 worth of 4D Molecular Therapeutics stock at the IPO in 2020 would have $-808 today, roughly -1 times their original investment - a -33.78% compound annual growth rate over 4 years.
The all-time high 4D Molecular Therapeutics stock closing price was 52.67 on February 11, 2021.
The 4D Molecular Therapeutics 52-week high stock price is 36.25, which is 365.3% above the current share price.
The 4D Molecular Therapeutics 52-week low stock price is 7.32, which is 6% below the current share price.
The average 4D Molecular Therapeutics stock price for the last 52 weeks is 19.64.
An investor who bought $1,000 worth of 4D Molecular Therapeutics stock at the IPO in 2020 would have $-808 today, roughly -1 times their original investment - a -33.78% compound annual growth rate over 4 years.
The all-time high 4D Molecular Therapeutics stock closing price was 52.67 on February 11, 2021.
The 4D Molecular Therapeutics 52-week high stock price is 36.25, which is 365.3% above the current share price.
The 4D Molecular Therapeutics 52-week low stock price is 7.32, which is 6% below the current share price.
The average 4D Molecular Therapeutics stock price for the last 52 weeks is 19.64.